NEW YORK (GenomeWeb News) – Shimadzu said today that it has registered several of its HPLC and LC-MS instruments as Class I medical devices with the US Food and Drug Administration, allowing them to be used in clinical settings.

The registration covers Shimadzu's LC-20 CL and LC-30 CL HPLCs; LC-MS-2020 CL single quadrupole mass spec; and LC-MS-8030 CL, LC-MS-8040 CL, and LC-MS-8050 CL triple quadrupole mass specs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.